The incubation period is contagious within 5 days of the onset of the disease is more contagious.

This edition of the treatment programme is revised on the basis of a summary of the experience of the previous treatment of neo-coronary pneumonia and reference to the guidelines of the World Health Organization and other countries.
clinical manifestations, the addition of "a very small number of children with multiple systemic inflammatory syndrome (MIS-C)" introduced the clinical manifestations of MIS-C.
laboratory tests, adding "new coronavirus-specific IgM antibodies, IgG antibodies with low positive rates within 1 week of onset" and conditions that could lead to false positives.
standards, the new coronavirus-specific IgM antibody positive as one of the basis for the diagnosis of suspected cases.
standards for the diagnosis of heavy cases in adults and children have been appropriately revised in clinical division.
the same time, the "heavy/critical high-risk population" criteria were increased and the "heavy/critically heavy warning indicators" for adults and children were adjusted.
in the identification diagnosis, increase "children with rashes, mucous membrane damage, need to be identified with Kawasaki disease."
in the detection and reporting of cases, the addition of "confirmed cases should be found within 2 hours of the network direct reporting."
In the area of antiviral therapy, treatment programmes have shown that some drugs may have some therapeutic effect after clinical observation studies have shown, but no antiviral drugs have been found to be effective after rigorous "randomized, double-blind, placebo-controlled studies".
recommends that potentially antiviral drugs be used early in the course of the disease, with a focus on patients with high risk factors and a tendency to be severely ill.
not recommended for lopineve/litonave and libawelin alone, hydroxychloroquine or a combination of azithromycin.
alpha-interferon, libavelin (recommended in combination with interferon or lopinave/litonave), chloroquine phosphate, Abidor can continue to be tested.
is not recommended to apply more than 3 antiviral drugs at the same time. the
treatment program adds "early rehabilitation" content, emphasizing the need to "pay attention to the early rehabilitation intervention of patients, for the new coronary pneumonia patients respiratory function, somatic function and psychological dysfunction, active rehabilitation training and intervention, as much as possible to restore physical fitness, physical fitness and immunity."
"care"-related content, according to the patient's condition, clear care priorities and do a good job of basic care.
stressed that patients with severe/critical illness should "closely observe the vital signs and consciousness status of patients, focusing on monitoring oxygen saturation."
" bedridden patients to prevent stress injuries.
in accordance with the nursing norms to do a variety of invasive treatment, invasive operation of nursing.
According to the diagnosis and treatment plan, for patients with temperature returning to normal for more than 3 days, respiratory symptoms significantly improved and lung imaging showing a significant improvement in acute oozing lesions, such as those with nucleic acids that remained positive for more than 4 weeks, it is recommended that "after a comprehensive assessment of the infectiousness of patients through antibody testing, virus culture separation, etc., it is recommended to determine whether to discharge the patient."
"